Orthocell CEO Paul Anderson on FDA approval, patient impact and US growth strategy

By Proactive Investors / December 31, 2025 / www.youtube.com / Article Link


Orthocell CEO and Managing Director Paul Anderson joins Proactive Newsroom to reflect on a landmark year for the company, ...

Recent News

Gold not the consensus play anymore

July 20, 2026 / www.canadianminingreport.com

Gold stocks drop to lowest levels this year

July 20, 2026 / www.canadianminingreport.com

A rebalancing of gold's ratios versus major commodities

July 14, 2026 / www.canadianminingreport.com

Gold stocks down on slide in gold price

July 14, 2026 / www.canadianminingreport.com

US tariff decision expected to be major copper catalyst

July 07, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok